4AB:ETR
AbbVie Common Stock
€231.00
arrow_downward
-0.35%(-0.80) 1D
Oct 2, 5:35:30 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€231.70
High
€232.90
Low
€229.50
Mkt. cap
464.43B
Avg. vol.
663.00
Volume
280.00
52-wk high
€237.60
52-wk low
€162.85
No. of employees
57K
Open
€231.70
High
€232.90
Low
€229.50
Mkt. cap
464.43B
Avg. vol.
663.00
Volume
280.00
52-wk high
€237.60
52-wk low
€162.85
No. of employees
57K
News stories
From web sources and news partners
The Motley Fool
·
3 hours ago
AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think.
AD HOC NEWS
·
4 hours ago
AbbVie presents new dermatology data. AbbVie stock costs EUR 233.55 in weekend trading
MarketWatch
·
16 hours ago
AbbVie Inc. stock outperforms competitors on strong trading day
TipRanks
·
20 hours ago
AbbVie’s Venetoclax AML Study in Greece: What the Latest Update Means for Investors
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com